A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

1,429

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Fibromyalgia Syndrome
Interventions
DRUG

milnacipran

DRUG

Placebo

Trial Locations (13)

2609

Center For Clinical Studies, Lillehamer

20157

Ospedale Luigi Sacco, Milan

43137

Gottfriesclinic Ab, Mölndal

70100

Kuopion Oma Laakari Oy, Kuopio

530 02

Rheumatology Ambulance, Pardubice

F2000

FREDERIKSBERG HOSPITAL - Clinic of Rheumatology, Frederiksberg

Unknown

Hopital Hotel Dieu, Paris

"Nasz Lekarz", Torun

D50931

KKSK KLINIKUM DER UNIVERSITAET ZU KOELN - Anaesthesiology and Intensive Care, Cologne

1349-019

Hospital Egas Moniz, Lisbon

020475

Dr I CANTACUZINO CLINICAL HOSPITAL, Bucharest

08024

Hospital de La Esperanza, Barcelona

SE59RJ

KINGS COLLEGE HOSPITAL - Clinic Trial Unit Academic Department of Rheumatology, London

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT00436033 - A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome | Biotech Hunter | Biotech Hunter